Tsuruha HoldingsTSUSF 69 EBITDA Margin % is 8.58% as of Feb. 2026, which is 27% above its 10-year median of 6.75. GuruFocus rates TSUSF with a GF Score™ of 69/100 and a GF Value™ of $22.33. The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Tsuruha Holdings ranks worse than 60.18% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tsuruha Holdings's EBITDA for the
three
months ended in Feb. 2026 was $341 Mil. Tsuruha Holdings's Revenue for the
three
months ended in Feb. 2026 was $3,979 Mil. Therefore, Tsuruha Holdings's EBITDA margin for the quarter that ended in Feb. 2026 was 8.58%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tsuruha Holdings EBITDA Margin % Related Terms
Tsuruha Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Tsuruha Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Tsuruha Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsuruha Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tsuruha Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tsuruha Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsuruha Holdings (TSUSF) has a EBITDA Margin % of 8.58% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tsuruha Holdings and its competitors. This is 27% above median its historical median of 6.75. Over the past decade, Tsuruha Holdings' EBITDA Margin % has ranged from 5.62 to 7.58. According to the industry distribution chart, Tsuruha Holdings ranks #402 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 60.2%.
Is Tsuruha Holdings' EBITDA Margin % too high?
Tsuruha Holdings' current EBITDA Margin % of 8.58% is 27% above median its 10-year median of 6.75. Over the past 10 years, this metric has ranged from a low of 5.62 to a high of 7.58. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Tsuruha Holdings' value of 8.58% is 16% below this industry median. Based on the distribution chart, Tsuruha Holdings ranks #402 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Tsuruha Holdings has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Tsuruha Holdings' EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Tsuruha Holdings ranks #402 out of 668 companies for EBITDA Margin %. This places Tsuruha Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Tsuruha Holdings' value of 8.58% is 16% below this benchmark. Historically, Tsuruha Holdings' own EBITDA Margin % has ranged from 5.62 to 7.58 over the past decade. While the company's 10-year median is 6.75 vs. the industry median of 10.21, Tsuruha Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tsuruha Holdings's current EBITDA Margin % of 8.58% is 16% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tsuruha Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsuruha Holdings's current EBITDA Margin % is 8.58%, which is 27% above median its own 10-year median of 6.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsuruha Holdings stock overvalued right now?
Tsuruha Holdings (TSUSF) has a current EBITDA Margin % of 8.58%. The stock's GF Value™ is $22.33, compared to a current price of $17.25 — trading 22.7% below its estimated fair value. The current EBITDA Margin % is 8.58%, which is 27% above median its 10-year median of 6.75 and 16% below the Healthcare Providers & Services industry median of 10.21. Tsuruha Holdings' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tsuruha Holdings (TSUSF), the current EBITDA Margin % is 8.58% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tsuruha Holdings (TSUSF) Overvalued in 2026?
Based on GuruFocus' analysis, Tsuruha Holdings stock appears to be undervalued.
The current stock price of $17.25 is trading 22.7% below its estimated GF Value™ of $22.33.
Key valuation signals for TSUSF:
EBITDA Margin %: 8.58% (27% above median its 10-year median of 6.75)
GF Value™: $22.33 vs. price of $17.25 (22.7% below fair value)
Industry Position: 16% below the Healthcare Providers & Services median (#402 of 668)
No single metric tells the full story. See the TSUSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. It also provides blood testing services, disease prevention solutions, and at-home drug delivery services.
69GF Score
Get the complete analysis for TSUSF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSUSF has been successfully added to your 
